Removal of dsRNA byproducts using affinity chromatography
Double-stranded RNA (dsRNA) molecules are immunogenic byproducts of <i>in vitro</i> transcription of single-stranded RNA (ssRNA). Removal of dsRNA from ssRNA is difficult because the byproducts have similar sizes, sequences, and charges to the desired ssRNA. Here, we describe a dsRNA-specific affinity resin that selectively removes dsRNA from ssRNA. Affinity purification reduced dsRNA levels by >100-fold, to as low as ∼0.00007% w/w of total mRNA, with no negative impact on RNA integrity. The purified RNA, synthesized with standard nucleotides, induced no inflammatory response in a reporter cell line assay designed to measure innate immune responses. Purified RNA induced greater protein expression and healthier cells. The immunogenicity of the affinity-purified RNA with standard nucleotides compares favorably to RNA synthesized with modified nucleotides and purified with cellulose or reverse-phase high-performance liquid chromatography (HPLC). dsRNA affinity purification provides a facile and scalable solution to the problem of immunogenic dsRNA byproducts in transcribed RNA. This approach will improve quality and safety of RNA vaccines and therapeutics.
Authors
- Kelley Kearns
- Thomas C. Scanlon (ORCID: https://orcid.org/0000-0002-4165-1171)
- Nathaniel E. Clark (ORCID: https://orcid.org/0000-0002-5478-1610)
- Roger A. Winters
- J. van den Heuvel
- Mateusz Kozarski
- Sinem Demirel Asci
- Matt R Schraut
- Senne Dillen
Institutions
- Galapagos (Belgium) (BE)
- Repligen (United States) (US)
Publication Details
- Journal
- Molecular Therapy — Nucleic Acids
- Published
- 2025-04-29
- DOI
- https://doi.org/10.1016/j.omtn.2025.102549
- Citations
- 8
- Primary Topic
- RNA regulation and disease
- Type
- article
- Field-Weighted Citation Impact
- 6.45